August 19, 2011 — The US Food and Drug Administration has granted accelerated approval of brentuximab vedotin infusion (Adcetris, Seattle Genetics, Inc) for the treatment of relapsed or refractory ...

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T‐cell lymphoma that emerges in the periprosthetic capsule surrounding breast implants, particularly those with a textured ...

The Food and Drug Administration issued a warning Wednesday about a rare and deadly cancer linked to breast implants. The agency said at least 457 women in the U.S. have been diagnosed with anaplastic ...

Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug ...